Iradimed Corp
IRMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.1B
Close$
$51.38
39.3% downside
Current Fair Value
39.3% downsideOvervalued by 39.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.10 Billion |
|---|---|
| Enterprise Value | $1.04 Billion |
| Dividend Yield | $1.27 (1.48%) |
| Earnings per Share | $1.77 |
| Beta | 0.91 |
| Outstanding Shares | 12,784,000 |
Return
| Return on Equity | 22.66% |
|---|---|
| Return on Assets | 20.05% |
| Return on Invested Capital | 26.91% |
Valuation & Multiples
| P/E Ratio | 47.15 |
|---|---|
| PEG | -489.72 |
| Price to Sales | 14.11 |
| Price to Book Ratio | 12.09 |
| Enterprise Value to Revenue | 12.07 |
| Enterprise Value to EBIT | 36.59 |
| Enterprise Value to Net Income | 45 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 31, 2026
EPS Estimate
$0.44
Average shareholder expectationRevenue Estimate
$20.35 M
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
$0.55
Average shareholder expectationRevenue Estimate
$23.47 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 122.22% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.98%▼ 57.98% |
|---|---|
| Total Invested | $43.84M▼ 94.21% |
| Investors Holding | 30▼ 188.00% |
ESG Score
No data
About Iradimed Corp
CEO: Roger Susi